AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $391,669 | -10.9% | 15,825 | +1.9% | 0.00% | -25.0% |
| Q2 2023 | $439,781 | +33.6% | 15,529 | +8.4% | 0.00% | +33.3% |
| Q1 2023 | $329,114 | -15.8% | 14,328 | +2.9% | 0.00% | -25.0% |
| Q4 2022 | $390,902 | +3.1% | 13,921 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $379,000 | +28.5% | 13,400 | +0.6% | 0.00% | +33.3% |
| Q2 2022 | $295,000 | -23.4% | 13,326 | +0.9% | 0.00% | 0.0% |
| Q1 2022 | $385,000 | -17.9% | 13,212 | -7.5% | 0.00% | -25.0% |
| Q4 2021 | $469,000 | -32.7% | 14,280 | -5.4% | 0.00% | -33.3% |
| Q3 2021 | $697,000 | -25.7% | 15,095 | -11.4% | 0.01% | -25.0% |
| Q2 2021 | $938,000 | +0.1% | 17,028 | -6.2% | 0.01% | 0.0% |
| Q1 2021 | $937,000 | +19.8% | 18,145 | +0.6% | 0.01% | +14.3% |
| Q4 2020 | $782,000 | +19.4% | 18,038 | -3.6% | 0.01% | 0.0% |
| Q3 2020 | $655,000 | -12.0% | 18,708 | +34.4% | 0.01% | -30.0% |
| Q2 2020 | $744,000 | +48.2% | 13,918 | -1.7% | 0.01% | +11.1% |
| Q1 2020 | $502,000 | – | 14,157 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |